Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
OtherPerspective
Open Access

Cervical cancer prevention in China: where are we now, and what’s next?

Huijiao Yan, Qiankun Wang and Youlin Qiao
Cancer Biology & Medicine March 2024, 21 (3) 213-217; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0432
Huijiao Yan
1School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
2Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qiankun Wang
1School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Youlin Qiao
1School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
2Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Youlin Qiao
  • For correspondence: qiaoy{at}cicams.ac.cn
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Article Information

vol. 21 no. 3 213-217
DOI 
https://doi.org/10.20892/j.issn.2095-3941.2023.0432
PubMed 
38172555

Published By 
Cancer Biology & Medicine
History 
  • Received November 8, 2023
  • Accepted December 11, 2023
  • Published online March 27, 2024.

Article Versions

  • previous version (January 2, 2024 - 02:47).
  • previous version (January 2, 2024 - 05:40).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright: © 2024, The Authors This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License.

Author Information

Funding

  • Research on Expending Human Papillomavirus (HPV) Vaccination

    INV–006373
  • Implementation Research around the Pilots of Cervical Cancer Elimination

    INV-031449

This work was supported by the Bill and Melinda Gates Foundation [Research on Expending Human Papillomavirus (HPV) Vaccination, Grant Number: INV–006373; and Implementation Research around the Pilots of Cervical Cancer Elimination, Grant Number: INV-031449].

Cited By...

  • 16 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Cancer Biology & Medicine: 21 (3)
Cancer Biology & Medicine
Vol. 21, Issue 3
15 Mar 2024
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Cancer Biology & Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cervical cancer prevention in China: where are we now, and what’s next?
(Your Name) has sent you a message from Cancer Biology & Medicine
(Your Name) thought you would like to see the Cancer Biology & Medicine web site.
Citation Tools
Cervical cancer prevention in China: where are we now, and what’s next?
Huijiao Yan, Qiankun Wang, Youlin Qiao
Cancer Biology & Medicine Mar 2024, 21 (3) 213-217; DOI: 10.20892/j.issn.2095-3941.2023.0432

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Cervical cancer prevention in China: where are we now, and what’s next?
Huijiao Yan, Qiankun Wang, Youlin Qiao
Cancer Biology & Medicine Mar 2024, 21 (3) 213-217; DOI: 10.20892/j.issn.2095-3941.2023.0432
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Cervical cancer (CC) epidemiology
    • CC elimination
    • HPV vaccination
    • CC screening and treatment
    • Future perspectives
    • Conflicts of interest statement
    • Author contributions
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Evaluation of an intelligent digital platform for population management in cervical cancer screening
  • China adds HPV shot as first new immunisation programme vaccine in 17 years
  • Google Scholar

More in this TOC Section

  • From bone marrow to the tumor microenvironment: how neutrophil maturation shapes cancer immunity
  • Immunological and metabolic optimization of tumor neoantigen vaccines
  • Chromatin relaxation dynamics and histone PTMs in the early DNA damage response
Show more Perspective

Similar Articles

Subjects

  • Cancer epidemiology
  • Gynecologic cancer

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire